These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
482 related items for PubMed ID: 19165648
1. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis. Dahlberg LE, Holme I, Høye K, Ringertz B. Scand J Rheumatol; 2009; 38(2):133-43. PubMed ID: 19165648 [Abstract] [Full Text] [Related]
2. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M. Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556 [Abstract] [Full Text] [Related]
3. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies. Schnitzer TJ, Weaver AL, Polis AB, Petruschke RA, Geba GP, VACT-1 and VACT-2 (Protocols 106 and 150) Study Groups. J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774 [Abstract] [Full Text] [Related]
4. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators. Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472 [Abstract] [Full Text] [Related]
5. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Kivitz A, Ma C, Ahdieh H, Galer BS. Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450 [Abstract] [Full Text] [Related]
6. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study. Emery P, Koncz T, Pan S, Lowry S. Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244 [Abstract] [Full Text] [Related]
7. Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial. Kellner HL, Li C, Essex MN. Curr Med Res Opin; 2012 Sep; 28(9):1537-45. PubMed ID: 22852870 [Abstract] [Full Text] [Related]
8. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Kivitz A, Fairfax M, Sheldon EA, Xiang Q, Jones BA, Gammaitoni AR, Gould EM. Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595 [Abstract] [Full Text] [Related]
9. Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies. Smugar SS, Schnitzer TJ, Weaver AL, Rubin BR, Polis AB, Tershakovec AM. Curr Med Res Opin; 2006 Jul; 22(7):1353-67. PubMed ID: 16834834 [Abstract] [Full Text] [Related]
11. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. Temple AR, Benson GD, Zinsenheim JR, Schweinle JE. Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643 [Abstract] [Full Text] [Related]
12. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials. Soni P, Shell B, Cawkwell G, Li C, Ma H. Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981 [Abstract] [Full Text] [Related]
13. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, Luta G, Callahan LF, Wang X, Schwartz T, Abramson SB, Caldwell JR, Harrell RA, Kremer JM, Lautzenheiser RL, Markenson JA, Schnitzer TJ, Weaver A, Cummins P, Wilson A, Morant S, Fort J. Arthritis Rheum; 2001 Jul; 44(7):1587-98. PubMed ID: 11465710 [Abstract] [Full Text] [Related]
14. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial. Pavelka K, Recker DP, Verburg KM. Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937 [Abstract] [Full Text] [Related]
16. Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis. Cheung R, Cheng TT, Dong Y, Lin HY, Lai K, Lau CS, Feng H, Parsons B. Int J Rheum Dis; 2010 May; 13(2):151-7. PubMed ID: 20536600 [Abstract] [Full Text] [Related]
17. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS. Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141 [Abstract] [Full Text] [Related]
18. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. Niethard FU, Gold MS, Solomon GS, Liu JM, Unkauf M, Albrecht HH, Elkik F. J Rheumatol; 2005 Dec; 32(12):2384-92. PubMed ID: 16331769 [Abstract] [Full Text] [Related]
19. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. Nadarajah A, Abrahan L, Lau FL, Hwang LJ, Fakir-Bolte C. Singapore Med J; 2006 Jun; 47(6):534-42. PubMed ID: 16752024 [Abstract] [Full Text] [Related]
20. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial. Gibofsky A, Williams GW, McKenna F, Fort JG. Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272 [Abstract] [Full Text] [Related] Page: [Next] [New Search]